Handelsbanken Fonder’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-29,300
| Closed | -$3.87M | – | 1582 |
|
|
2025
Q1 | $3.87M | Buy |
29,300
+2,200
| +8% | +$290K | 0.02% | 470 |
|
|
2024
Q4 | $2.26M | Buy |
27,100
+800
| +3% | +$66.8K | 0.01% | 629 |
|
|
2024
Q3 | $1.92M | Buy |
26,300
+5,000
| +23% | +$366K | 0.01% | 678 |
|
|
2024
Q2 | $1.46M | Buy |
21,300
+2,800
| +15% | +$192K | 0.01% | 688 |
|
|
2024
Q1 | $1.28M | Hold |
18,500
| – | – | 0.01% | 746 |
|
|
2023
Q4 | $1.33M | Buy |
18,500
+1,100
| +6% | +$78.8K | 0.01% | 690 |
|
|
2023
Q3 | $906K | Buy |
17,400
+2,000
| +13% | +$104K | 0.01% | 771 |
|
|
2023
Q2 | $975K | Buy |
15,400
+3,600
| +31% | +$228K | 0.01% | 754 |
|
|
2023
Q1 | $639K | Hold |
11,800
| – | – | ﹤0.01% | 895 |
|
|
2022
Q4 | $624K | Hold |
11,800
| – | – | ﹤0.01% | 838 |
|
|
2022
Q3 | $549K | Hold |
11,800
| – | – | ﹤0.01% | 904 |
|
|
2022
Q2 | $674K | Hold |
11,800
| – | – | ﹤0.01% | 841 |
|
|
2022
Q1 | $722K | Sell |
11,800
-3,600
| -23% | -$220K | ﹤0.01% | 956 |
|
|
2021
Q4 | $806K | Hold |
15,400
| – | – | ﹤0.01% | 1016 |
|
|
2021
Q3 | $574K | Hold |
15,400
| – | – | ﹤0.01% | 1270 |
|
|
2021
Q2 | $629K | Buy |
15,400
+4,000
| +35% | +$163K | ﹤0.01% | 1210 |
|
|
2021
Q1 | $387K | Hold |
11,400
| – | – | ﹤0.01% | 1326 |
|
|
2020
Q4 | $363K | Hold |
11,400
| – | – | ﹤0.01% | 1321 |
|
|
2020
Q3 | $293K | Hold |
11,400
| – | – | ﹤0.01% | 1259 |
|
|
2020
Q2 | $293K | Buy |
+11,400
| New | +$293K | ﹤0.01% | 1229 |
|